Search results
Contemporary Cardiology > Asymptomatic Atherosclerosis > > 77-85
Contemporary Cardiology > Asymptomatic Atherosclerosis > Non Invasive Structural Imaging of Subclinical Atherosclerosis > 363-373
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > The Impact of Diet > 263-300
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > Targets of Future Anti-Atherosclerotic Drug Therapy > 777-783
Contemporary Cardiology > Asymptomatic Atherosclerosis > Educations, Life Style Modifications and Non-pharmacologic Therapies for the Atherosclerosis Susceptible and ACVD Vulnerable Population > 689-697
Contemporary Cardiology > Asymptomatic Atherosclerosis > Treatment of Asymptomatic Atherosclerotic Cardiovascular Disease and the Vulnerable Patients: Systemic Therapies > 605-619
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > Evidence-Based Anti-Atherosclerotic Drug Therapy > 389-406
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > Targets of Future Anti-Atherosclerotic Drug Therapy > 723-743
Contemporary Cardiology > Asymptomatic Atherosclerosis > Non Invasive Structural Imaging of Subclinical Atherosclerosis > 357-361
Contemporary Cardiology > Asymptomatic Atherosclerosis > Non Invasive, Non Imaging, Assessment of Atherosclerotic Cardiovascular Disease > 211-223
Contemporary Cardiology > Asymptomatic Atherosclerosis > Methods for the Detection of Subclinical Atherosclerotic Cardiovascular Disease > 119-133
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > The Impact of Diet > 195-213
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > Targets of Future Anti-Atherosclerotic Drug Therapy > 785-807
Contemporary Cardiology > Asymptomatic Atherosclerosis > > 13-38
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > Targets of Future Anti-Atherosclerotic Drug Therapy > 645-663
Contemporary Cardiology > Asymptomatic Atherosclerosis > Screening for Risk Assessment of Asymptomatic At-Risk Population and Identification of the Vulnerable Patient – The SHAPE Paradigm > 517-535
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > Evidence-Based Anti-Atherosclerotic Drug Therapy > 443-462
Contemporary Cardiology > Asymptomatic Atherosclerosis > Treatment of Asymptomatic Atherosclerotic Cardiovascular Disease and the Vulnerable Patients: Systemic Therapies > 649-657
Contemporary Cardiology > Asymptomatic Atherosclerosis > Non Invasive Functional Imaging of Subclinical Atherosclerosis > 411-427
Handbook of Experimental Pharmacology > Atherosclerosis: Diet and Drugs > Targets of Future Anti-Atherosclerotic Drug Therapy > 619-644